drugset / Trial / NCT06381206

Silodosin in Management of Lower Ureteral Stones

NCT06381206

Phase 1/2 Completed 100 enrolled Syrian Private University
RandomizedParallel-groupOpen-labelTreatment

Summary

This research aims to study the effectiveness of silodosin in the management of lower ureter stones larger than 6 mm in diameter in terms of affected ureter (right or left), the size of the stone, the degree of hydronephrosis, the rate of stone expulsion(day), whether the stone was completely expelled or not, and the side effects of silodosin.

Timeline

Start
2022-10-20
Primary completion
2023-10-20
Completion
2023-10-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Silodosin Unknown

Indications